The protective effect of plasma antioxidants during ozone autohemotherapy

African Journal of Biotechnology

Volumn 7, Issue 14, 2008, Pages 2472-2477

  Du Plessis, L H ^a   Van Der Westhuizen, F H ^a   Kotze H F ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

Author keywords

Antioxidant enzymes; Glutathione; Oxidant antioxidant status; Ozone autohemotherapy; Plasma antioxidants

Indexed keywords

ANTIOXIDANT; CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HYDROPEROXIDE; OXYGEN; OZONE; PHOSPHATE BUFFERED SALINE; SUPEROXIDE DISMUTASE;

ALTERNATIVE MEDICINE; ARTICLE; AZONE AUTOHEMOTHERAPY; BLOOD VOLUME; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMA; VENOUS BLOOD;

EID: 48149115520     PISSN: None     EISSN: 16845315     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Ajamieh HH, Menendez S, Merino N, Candelario-Jalil E, Leon OS (2002). Similar protective effect of ischeamic and ozone oxidative preconditionings in liver ischeamia repurfusion injury. Pharmacol. Res. 45: 333-339.
2. Al-Dalain SM, Martinez G, Candelario-Jalil E, Menendez S, Re L, Giuliani A, Leon OS (2001). Ozone treatment reduces markers of oxidative and endothelial damage in an experimental diabetes model in rats. Pharmacol. Res. 44: 391-396.
3. Asensi M, Sastre J, Pallardo FV, Lloret A, Lehner M, Garcia-de-la Asuncion J, Vina J (1999). Ratio of reduced to oxidized glutathione as indicator of oxidative stress status and DNA damage. Methods Enzymol. 299: 267-276.
4. Berman K, Brodaty H (2004). Tocopherol (vitamin E) in Alzheimer's disease and other neurodegenerative disorders. Central Nervous System Drugs. 18: 807-825.
5. Benzie IF, Strain JJ (1999). Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concnetration. Methods. Enzymol. 299: 15-27.
6. Bocci V (1996). Does ozone therapy normalize the cellular redox balance? Implications for therapy of human immunodeficiency virus infection and several other diseases. Med. Hypotheses. 46: 150-154.
7. Bocci V, Valacchi G, Corradeschi F, Fanetti G (1998). Studies on the biological effects of ozone: 8. Effects on the total antioxidant status and on interleukin-8 production. Mediat. Inflamm. 7: 313-317.
8. Bocci V, Aldinucci C, Borrelli E, Corradeschi F, Diadori A, Fanetti G, Valacchi G (2001). Ozone in medicine. Ozone-sci Eng. 23: 207-217.
9. Bocci V (2002). Oxygen-ozone therapy, a critical evaluation. Kluwer academic publishers.
10. Cao G, Prior RL (1999). Measurement of oxygen radical absorbance capacity in biological samples. Methods. Enzymol. 299: 50-62.
11. Cross CE, Motchnik PA, Bruener BA, Jones DA, Kaur H, Ames BN, Halliwell B (1992). Oxidative damage to plasma constituents by ozone. FEBS. Lett. 298: 269-272.
12. Ellerby LM, Bredesen DE (2000). Measurement of cellular oxidation, reactive oxygen species and antioxidant enzymes during apoptosis. San Diego, California. Academic Press.
13. Higuchi Y (2004). Glutathione depletion-induced chromosomal DNA fragmentation associated with apoptosis and necrosis. J. Cell. Mol. Med. 8:455-464.
14. Iorio EL (2002). d-ROMs test and oxidative stress assessment. Diacron International. Grosseto, Italy.
15. Jordan L, Beaver K, Foy S (2002). Ozone treatment for radiotherapy skin reactions: is there an evidence base for practice? Eur. J. Oncol Nurs. 6: 220-227.
16. Larini A, Aldinucci C, Bocci V (2001). Ozone as a modulator of the immune system. International ozone association. Proceedings - 15th World congress. Imperial college, London, UK.
17. Larini A, Bianchi L, Bocci V (2003). The ozone tolerance: I) Enhancement of antioxidant enzymes is ozone dose-dependent in Jurkat cells. Free. Radical. Res. 37: 1163-1168.
18. Larini A, Bocci V (2005). Effects of ozone on isolated peripheral blood mononuclear cells. Toxicol. In Vitro. 19: 55-61.
19. Mates JM, Perez-Gomez C, Nunez De Castro I (1999). Antioxidant enzymes and human diseases. Clin. biochem. 32: 595-603.
20. Mudway IS, Kelly FJ (2000). Ozone and the lung: a sensitive issue. Mol. Aspects. Med. 21:1-48.
21. Pastore A, Federici G, Bertini E, Piemonte F (2003). Analysis of glutathione: implication in redox and detoxification. Clin. Chim. Acta. 333: 19-39.
22. Pryor WA, Squadrito GL, Friedman M (1995). The cascade mechanism to explain ozone toxicity: the role of lipid ozonation products. Free. Radic. Biol. Med. 19: 935-941.
23. Shallenberger F (1998). Selective compartmental dominance: an explanation for a noninfectious, multifactorial etiology for acquired immune deficiency syndrome (AIDS), and a rationale for ozone therapy and other immune modulating therapies. Med. Hypotheses. 50: 67-80.
24. Van Helden G (2005). The effects of ozone autohemotherapy on antioxidant status and DNA integrity in baboons. Biochemistry. Potchefstroom, North-West University.
25. Viebahn-Hansler R, Lell B, Kremsner PG (2001). The effect of ozone on Plasmodium falciparum-infected red blood cells. International ozone association. Proceedings- 15th World congress. Imperial college, London. UK.
26. Witschi H, Espiritu I, Pinkerton KE, Murphy K, Maronpot RR (1999). Ozone carcinogenesis revisited. Toxicol. Sci. 52: 162-167.